ALTERITY THERAPEUTICS LTD
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$2.16
-3.29%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-38.1%
3 months
-51.5%
6 months
-54.3%
1 year
-53.0%
Year to date
-29.9%
52-week range
$2.08 – $5.89
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$39.2M
P/E
-2.3
P/B
1.3
P/S
15.2
Revenue
$3.61M
Net income
-$23.4M
Diluted EPS
-1.33
Gross margin
100.00%
Net margin
-648.20%
Return on equity
-55.00%
Total debt
$193.47K
Cash
$37.32M
Free cash flow
-$22.52M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | — | — | — | — | — |
| Dec 31, 2025 | — | — | — | — | — |
| Jun 30, 2025 | — | — | — | — | — |
| Dec 31, 2024 | — | — | — | — | — |
| Jun 30, 2024 | — | — | — | — | — |
| Jun 30, 2024 | — | — | — | — | — |
| Dec 31, 2023 | — | — | — | — | — |
| Jun 30, 2023 | — | — | — | — | — |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ATHE news
All market newsNo ticker-linked stories are in the current archive.